Alzamend Neuro, Inc. (ALZN)
1.68
+0.02
(+1.20%)
USD |
NASDAQ |
Sep 08, 16:00
1.71
+0.03
(+1.79%)
Pre-Market: 20:00
Alzamend Neuro Price : 1.68 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.66 | 1.717 | 1.62 | 1.68 | 31191.00 |
| Sep 04, 2026 | 1.70 | 1.73 | 1.65 | 1.66 | 63178.00 |
| Sep 03, 2026 | 1.65 | 1.72 | 1.65 | 1.70 | 128250.0 |
| Sep 02, 2026 | 1.65 | 1.70 | 1.565 | 1.70 | 101096.0 |
| Sep 01, 2026 | 1.615 | 1.68 | 1.615 | 1.637 | 23299.00 |
| Aug 31, 2026 | 1.655 | 1.655 | 1.51 | 1.60 | 37767.00 |
| Aug 28, 2026 | 1.64 | 1.72 | 1.64 | 1.66 | 242129.0 |
| Aug 27, 2026 | 1.67 | 1.67 | 1.65 | 1.665 | 39916.00 |
| Aug 26, 2026 | 1.59 | 1.67 | 1.55 | 1.67 | 128311.0 |
| Aug 25, 2026 | 1.53 | 1.65 | 1.501 | 1.60 | 122090.0 |
| Aug 24, 2026 | 1.51 | 1.58 | 1.41 | 1.55 | 133883.0 |
| Aug 21, 2026 | 1.57 | 1.598 | 1.49 | 1.56 | 244126.0 |
| Aug 20, 2026 | 1.56 | 1.67 | 1.532 | 1.63 | 486200.0 |
| Aug 19, 2026 | 1.50 | 1.60 | 1.50 | 1.52 | 95128.00 |
| Aug 18, 2026 | 1.52 | 1.576 | 1.51 | 1.52 | 37532.00 |
| Aug 17, 2026 | 1.531 | 1.59 | 1.481 | 1.58 | 118646.0 |
| Aug 14, 2026 | 1.46 | 1.55 | 1.445 | 1.55 | 87577.00 |
| Aug 13, 2026 | 1.43 | 1.46 | 1.414 | 1.46 | 25272.00 |
| Aug 12, 2026 | 1.455 | 1.46 | 1.41 | 1.44 | 19937.00 |
| Aug 11, 2026 | 1.43 | 1.47 | 1.43 | 1.47 | 16360.00 |
| Aug 10, 2026 | 1.38 | 1.46 | 1.38 | 1.46 | 27729.00 |
| Aug 07, 2026 | 1.38 | 1.421 | 1.35 | 1.37 | 18077.00 |
| Aug 06, 2026 | 1.42 | 1.45 | 1.33 | 1.38 | 59386.00 |
| Aug 05, 2026 | 1.42 | 1.45 | 1.380 | 1.43 | 43429.00 |
| Aug 04, 2026 | 1.38 | 1.45 | 1.340 | 1.45 | 149551.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.58 |
| Alnylam Pharmaceuticals, Inc. | 260.10 |
| Anika Therapeutics, Inc. | 21.04 |
| Savara, Inc. | 5.53 |
| Vericel Corp. | 39.08 |
Price Related Metrics
| Price to Book Value | 9.752 |
| Earnings Yield | -172.4% |
| Market Cap | 7.150M |